الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 148 |  |  |
| | | from | 148 | | |
Abstract
The study was approved by the responsible authorities and consent was secured from all patients. Patients were randomly allocated into three main groups according to the muscle relaxant used: Group 1Tc(n=10 ): patients had laparotomies for non malignant procedures and received atracurium muscle relaxant 0.5mg/kg bolus dose and 0.1mg/kg incriments. Group 2 Tm(n=10): patients had laparotomies for malignant procedures and received atracurium muscle relaxant 0.5mg/kg bolus dose and 0.1mg/kg incriments. Group 3 Vc(n=10): patients had laparotomies for non malignant procedures and received vecuronium muscle relaxant 0.1mg/kg bolus dose and 0.02mg/kg incriments. Group 4 Vm(n=10): patients had laparotomies for malignant procedures and received vecuronium muscle relaxant 0.1mg/kg bolus dose and 0.02mg/kg incriments. Group 5 Cc(n=10): patients had laparotomies for non malignant procedures and received cisatracurium muscle relaxant 0.1mg/kg bolus dose and 0.02mg/kg incriments. Group 6 Cm(n=10): patients had laparotomies for malignant procedures and received cisatracurium muscle relaxant 0.1mg/kg bolus dose and 0.02mg/kg incriments